Patents by Inventor Christen A Rees

Christen A Rees has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10102344
    Abstract: A system and technique are enclosed for determining the effectiveness of a blood glucose therapy treatment. Examples of this technique include analyzing sufficiency of blood glucose data collected from a patient with a computing device, analyzing hypoglycemic risk based on the blood glucose data with the computing device, analyzing glycemic control for the blood glucose data with the computing device, analyzing glycemic variability of the blood glucose data with the computing device, and outputting results from said analyzing the sufficiency, said analyzing the hypoglycemic risk, said analyzing the glycemic control, and said analyzing the glycemic variability with the computing device.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: October 16, 2018
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Christen A Rees, Robin Wagner, Nathan Wegmann
  • Patent number: 9999398
    Abstract: A computer implemented method for transmitting messages generated by a continuous glucose monitor (CGM), the method comprising: generating a first message at the CGM at a first time, the first message being related to blood glucose measuring; generating a second message at the CGM at a second time, the second time being after the first time, the second message being related to blood glucose measuring; determining an elapsed time since a transmitter of the CGM has transmitted data; determining whether the elapsed time is greater than a threshold; determining whether the second message is to be transmitted before the first message, in response to the elapsed time being greater than the threshold; and transmitting data corresponding with the second message before transmitting data corresponding with the first message to a diabetes management device, in response to determining that the second message is to be transmitted before the first message.
    Type: Grant
    Filed: September 4, 2013
    Date of Patent: June 19, 2018
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Christen A. Rees, Sheldon A. White
  • Patent number: 9965587
    Abstract: A method includes: measuring a blood glucose (bG) level in a blood sample; storing the bG level and a time of receipt of the blood sample; storing a classification of the blood sample; in response to the receipt of the blood sample, selecting a group of stored bG levels having the classification of the blood sample and that were received within a predetermined period before receipt of the blood sample; calculating a bG evaluation parameter from the selected bG levels; evaluating the bG evaluation parameter in relation to first predetermined criteria, the first predetermined criteria including a first threshold indicative of a high bG level or a low bG level; selectively displaying an indication of recognition of a pattern in the selected bG levels when the bG evaluation parameter is greater than or less than the first threshold; and selectively removing the indication from the display.
    Type: Grant
    Filed: July 8, 2013
    Date of Patent: May 8, 2018
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Timothy N. Aykroyd, Amy C. Day, Paul J. Galley, Horst Merkle, Christen A. Rees, Michelle M. Stevens, Scott A. Wooldridge
  • Publication number: 20150095042
    Abstract: A blood glucose (bG) measurement engine selectively measures bG levels in blood samples input to a handheld diabetes management device. A computer readable medium includes code executed by a processor to: identify a period of N days, the period including the current date and N?1 days immediately prior to the current date, wherein N is an integer greater than 6; determine a total number of the N days during which the patient input at least two blood samples; and, when the total number of the N days is greater than M, M being an integer greater than zero and less than or equal to N: calculate a value based on the bG levels of blood samples input during the period; based on the value, classify the patient as having a first, second, or third risk of being hypoglycemic in the future.
    Type: Application
    Filed: September 27, 2013
    Publication date: April 2, 2015
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Timothy N. Aykroyd, Amy C. Day, Paul J. Galley, Sebastiaan la Bastide, Christen A. Rees, Nigel A. Surridge
  • Publication number: 20150061890
    Abstract: A computer implemented method for transmitting messages generated by a continuous glucose monitor (CGM), the method comprising: generating a first message at the CGM at a first time, the first message being related to blood glucose measuring; generating a second message at the CGM at a second time, the second time being after the first time, the second message being related to blood glucose measuring; determining an elapsed time since a transmitter of the CGM has transmitted data; determining whether the elapsed time is greater than a threshold; determining whether the second message is to be transmitted before the first message, in response to the elapsed time being greater than the threshold; and transmitting data corresponding with the second message before transmitting data corresponding with the first message to a diabetes management device, in response to determining that the second message is to be transmitted before the first message.
    Type: Application
    Filed: September 4, 2013
    Publication date: March 5, 2015
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Christen A. Rees, Sheldon A. White
  • Publication number: 20150012223
    Abstract: A method includes: measuring a blood glucose (bG) level in a blood sample; storing the bG level and a time of receipt of the blood sample; storing a classification of the blood sample; in response to the receipt of the blood sample, selecting a group of stored bG levels having the classification of the blood sample and that were received within a predetermined period before receipt of the blood sample; calculating a bG evaluation parameter from the selected bG levels; evaluating the bG evaluation parameter in relation to first predetermined criteria, the first predetermined criteria including a first threshold indicative of a high bG level or a low bG level; selectively displaying an indication of recognition of a pattern in the selected bG levels when the bG evaluation parameter is greater than or less than the first threshold; and selectively removing the indication from the display.
    Type: Application
    Filed: July 8, 2013
    Publication date: January 8, 2015
    Inventors: Timothy N. Aykroyd, Amy C. Day, Paul J. Galley, Horst Merkle, Christen A. Rees, Michelle M. Stevens, Scott A. Wooldridge
  • Publication number: 20140278124
    Abstract: A system and technique are enclosed for determining the effectiveness of a blood glucose therapy treatment. Examples of this technique include analyzing sufficiency of blood glucose data collected from a patient with a computing device, analyzing hypoglycemic risk based on the blood glucose data with the computing device, analyzing glycemic control for the blood glucose data with the computing device, analyzing glycemic variability of the blood glucose data with the computing device, and outputting results from said analyzing the sufficiency, said analyzing the hypoglycemic risk, said analyzing the glycemic control, and said analyzing the glycemic variability with the computing device.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 18, 2014
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Christen A Rees, Robin Wagner, Nathan Wegmann